Related Experiment Video
Updated: Jan 25, 2026

Author Spotlight: A Computational Pipeline for Analyzing Chimeric Noncoding RNA-Target RNA Interactions in High-Throughput Sequencing Data
Published on: December 1, 2023
Long noncoding RNA/circular noncoding RNA-miRNA-mRNA axes in cardiovascular diseases
Ming Li1, Liwei Duan1, Yangxue Li2
1Department of Gastroenterology, The Second Hospital of Jilin University, 218 Ziqiang Road, Changchun 130041, China.
Non-coding RNAs, including long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and microRNAs (miRNAs), play key roles in cardiovascular diseases (CVDs). Understanding their complex interactions, known as the lncRNA/circRNA-miRNA-mRNA axis, is crucial for developing new CVD therapies.
Area of Science:
- Molecular Biology
- Genetics
- Cardiology
Background:
- Cardiovascular diseases (CVDs) represent a significant global health burden, being the primary cause of mortality worldwide.
- Non-coding RNAs (ncRNAs), encompassing long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and microRNAs (miRNAs), are increasingly recognized for their involvement in CVD pathogenesis.
- The intricate regulatory networks formed by these ncRNAs, specifically the lncRNA/circRNA-miRNA-mRNA axis, are emerging as critical players in cardiovascular health and disease.
Purpose of the Study:
- To review and synthesize current research on the lncRNA/circRNA-miRNA-mRNA axis in the context of various cardiovascular diseases.
- To elucidate the molecular mechanisms underlying the roles of these ncRNA interactions in CVD development.
- To highlight the potential of targeting these axes for novel therapeutic strategies in cardiovascular medicine.
Main Methods:
- Comprehensive literature review of recent studies focusing on ncRNA interactions in CVDs.
- Analysis of molecular mechanisms involving lncRNA, circRNA, miRNA, and mRNA crosstalk.
- Synthesis of findings related to specific CVDs such as atherosclerosis, myocardial infarction, hypertrophy, heart failure, and cardiomyopathy.
Main Results:
- The lncRNA/circRNA-miRNA-mRNA axis is implicated in the pathological processes of diverse cardiovascular conditions.
- These ncRNA networks regulate gene expression at multiple levels, influencing cellular functions relevant to CVDs.
- Specific examples of axis-mediated regulation in atherosclerosis, myocardial infarction, and heart failure are detailed.
Conclusions:
- The lncRNA/circRNA-miRNA-mRNA axis represents a complex regulatory system critical to cardiovascular disease development.
- Understanding these molecular interactions provides insights into disease pathogenesis and identifies potential therapeutic targets.
- Further research into this axis holds promise for advancing the treatment and prevention of cardiovascular diseases.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Stability
RNA Editing
RNA Structure
The basic structure of RNA consists of a five-carbon sugar and one of four nitrogenous bases. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA): messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three RNA types consist of a...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...

